Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
35.78
+0.51 (1.45%)
May 16, 2025, 10:10 AM - Market open
Sarepta Therapeutics Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$131.09
Upside
+266.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $115 → $100 | Buy | Maintains | $115 → $100 | +179.49% | May 8, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $87 → $58 | Hold | Maintains | $87 → $58 | +62.10% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $178 → $100 | Strong Buy | Maintains | $178 → $100 | +179.49% | May 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $112 → $98 | Strong Buy | Maintains | $112 → $98 | +173.90% | May 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $70 | Buy | Maintains | $110 → $70 | +95.64% | May 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $184 → $123 | Buy | Maintains | $184 → $123 | +243.77% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $163 → $81 | Buy | Maintains | $163 → $81 | +126.38% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $75 → $40 | Hold | Maintains | $75 → $40 | +11.79% | May 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $182 → $113 | Buy | Maintains | $182 → $113 | +215.82% | May 7, 2025 |
| Needham | Needham | Strong Buy Maintains $183 → $125 | Strong Buy | Maintains | $183 → $125 | +249.36% | May 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $182 → $110 | Buy | Maintains | $182 → $110 | +207.43% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +109.61% | Apr 16, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $196 → $182 | Buy | Maintains | $196 → $182 | +408.66% | Apr 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $115 | Buy | Initiates | $115 | +221.41% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +109.61% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +109.61% | Apr 4, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.